EQ

Conviction 80HealthcareScan · Thu, Jun 25, 2026

EQ$2.97+4.21%

ResistanceSupportVol 14Insider sell

Vol MA14 474.57K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Equillium, Inc.PHARMACEUTICAL PREPARATIONSwww.equilliumbio.com ↗

Price2.97

Change+4.21%

Gap+2.81%

Rel volume0.35×

Avg volume1.14M

Avg $ vol3.4M

SMA 202.89

SMA 502.44

SMA 2001.72

Price vs 50+21.56%

Price vs 200+73.18%

MA stackbullish

50/200 cross—

Supertrendup · 2.15

RSI (14)59

MACD hist-0.02

MACD cross—

Stoch %K / %D66 / 41

ADX (14)18

+DI / −DI21 / 18

RSI divergence—

MACD divergence—

ATR %+9.56%

ADR %11.14%

52w high3.17

52w low0.3100

From 52w high-6.31%

Above 52w low+858.06%

New 52w highNo

SqueezeOn · 2d

Bollinger width18.70%

%B0.66

Donchian pos60.66%

Donchian high3.45

Donchian low2.23

AVWAP (52w high)2.99

vs AVWAP high-0.62%

AVWAP (52w low)1.16

vs AVWAP low+155.76%

OBV trendUp

Chaikin MF (20)0.15

Today vs 20d0.35×

Avg vol (14d)474.57K

Avg vol (20d)1.14M

Avg $ vol (20d)3.4M

Market cap187.78M

RS 3m (vs SPY)+33.90%

RS 6m (vs SPY)+140.09%

RS line new highNo

Trend template8/8

Technical rank93.5

1 week-0.67%

1 month+28.02%

3 months+44.17%

6 months+112.14%

1 year+735.44%

YTD+94.12%

P/E-8.38

P/B3.16

P/S4.57

P/FCF-8.24

EPS-0.3900

Div yield—

ROE-37.65%

ROA-35.51%

Debt/Eq0.13

Current18.62

EV/EBITDA-5.70

Gross margin—

Net margin-54.50%

Rev growth0.00%

EPS growth-177.65%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value134.02M

Revenue12.16M

Net income-5.31M

Gross profit—

Free cash flow-22.79M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out63.23M

Employees14

ListedFri, Oct 12, 2018

Free float44.78M

Float %70.8%

Short interest3.61M

Days to cover6.0d

Short volume41.6%

Squeeze score42 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank93.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.30

Support1.86

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EQ

All disclosures →

No recent disclosed trades by Congress in EQ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EQ · 5 buys · 5 sells

Insider	Side	Shares	Value	Traded	Filed
Zedelmayer Christine Sr. Vice President and COO · Employee Stock Option (right to buy) · 2026-06-05	Exercise	14.58K	$0	2026-06-05	2026-06-05
Zedelmayer Christine Sr. Vice President and COO · Common Stock · 2026-06-05	Exercise	14.58K	$11K	2026-06-05	2026-06-05
Connelly Stephen President and CSO · Common Stock · 2026-06-05	Sell	30.98K	$91K	2026-06-05	2026-06-05
Zedelmayer Christine Sr. Vice President and COO · Common Stock · 2026-06-05	Sell	14.58K	$43K	2026-06-05	2026-06-05
Connelly Stephen President and CSO · Common Stock · 2026-06-04	Sell	200K	$633K	2026-06-04	2026-06-05
BRADBURY DANIEL CHAIRMAN · Director stock option (right to buy) · 2026-05-28	Grant	70K	$0	2026-05-28	2026-05-29
McDermott Charles Douglas Director · Director Stock Option (right to buy) · 2026-05-28	Grant	70K	$0	2026-05-28	2026-05-29
Zedelmayer Christine Sr. Vice President and COO · Common Stock · 2026-05-28	Exercise	14.58K	$11K	2026-05-28	2026-05-29
Zedelmayer Christine Sr. Vice President and COO · Employee Stock Option (right to buy) · 2026-05-28	Exercise	7.29K	$0	2026-05-28	2026-05-29
Tom Penny Principal Accounting Officer · Common Stock · 2026-05-28	Exercise	65K	$51K	2026-05-28	2026-05-29

SEC filings

EDGAR filings in EQ · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.